Related Experiment Videos
Elevated energy expenditure in cancer patients with solid tumours
A Hyltander1, C Drott, U Körner
1Department of Surgery, Sahlgrenska Hospital, University of Gothenburg, Sweden.
Summary
Cancer patients exhibit higher resting energy expenditure (REE) and fat oxidation, contributing to weight loss. This increased metabolic rate is linked to elevated heart rate, suggesting an adrenergic mechanism independent of malnutrition.
Area of Science:
- Metabolic research
- Oncology
- Human physiology
Background:
- Cancer-associated weight loss is a significant clinical issue.
- Understanding the metabolic alterations in cancer patients is crucial for effective management.
- Previous studies suggest altered energy expenditure in cancer, but mechanisms require further elucidation.
Purpose of the Study:
- To investigate resting energy expenditure (REE) and substrate oxidation in cancer patients compared to controls.
- To identify factors predicting elevated energy expenditure.
- To explore the relationship between metabolic changes and weight loss in cancer.
Main Methods:
- Comparison of REE and fat oxidation between cancer patients and non-cancer controls (weight-stable and weight-losing).
- Measurement of heart rate, thyroid hormones, and liver function.
- Statistical analysis to identify predictors of high energy expenditure.
Main Results:
- Cancer patients demonstrated significantly elevated REE and fat oxidation compared to both weight-losing and weight-stable controls.
- Elevated energy expenditure was counter-regulated by decreased thyroid hormones.
- Heart rate was a strong predictor of high energy expenditure, particularly in cancer patients.
- Abnormal liver function did not impact REE.
Conclusions:
- Increased metabolic rate, characterized by elevated REE and fat oxidation, is a key factor in cancer-related weight loss, independent of malnutrition.
- An elevated adrenergic state is a likely explanation for the increased metabolic rate in cancer patients.
- Heart rate serves as a significant indicator of heightened energy expenditure in cancer.